Healthcare provider profile · identity verified

Nathaniel A Enders, M.D.

Internal Medicine · MEDINA, OH · NPI 1669748240

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	525	186
Amlodipine Besylate	Amlodipine Besylate	431	159
Lisinopril	Lisinopril	292	104
Levothyroxine Sodium	Levothyroxine Sodium	276	92
Rosuvastatin Calcium	Rosuvastatin Calcium	244	86
Pantoprazole Sodium	Pantoprazole Sodium	225	85
Losartan Potassium	Losartan Potassium	223	78
Hydrochlorothiazide	Hydrochlorothiazide	203	72
Omeprazole	Omeprazole	203	74
Prednisone	Prednisone	188	155
Metformin Hcl Er	Metformin Hcl	143	51
Metoprolol Succinate	Metoprolol Succinate	143	60
Potassium Chloride	Potassium Chloride	143	45
Gabapentin	Gabapentin	141	70
Trazodone Hcl	Trazodone Hcl	140	58
Sertraline Hcl	Sertraline Hcl	134	54
Eliquis	Apixaban	129	37
Carvedilol	Carvedilol	122	41
Meloxicam	Meloxicam	114	57
Tamsulosin Hcl	Tamsulosin Hcl	110	44
Furosemide	Furosemide	108	45
Metformin Hcl	Metformin Hcl	108	35
Fluticasone Propionate	Fluticasone Propionate	102	59
Celecoxib	Celecoxib	101	56
Metoprolol Tartrate	Metoprolol Tartrate	99	32
Pravastatin Sodium	Pravastatin Sodium	96	35
Duloxetine Hcl	Duloxetine Hcl	92	29
Alprazolam	Alprazolam	91	39
Bupropion Xl	Bupropion Hcl	82	23
Doxycycline Monohydrate	Doxycycline Monohydrate	82	62
Albuterol Sulfate Hfa	Albuterol Sulfate	80	48
Tramadol Hcl	Tramadol Hcl	77	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	74	22
Allopurinol	Allopurinol	73	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	73	21
Jardiance	Empagliflozin	65	19
Fluoxetine Hcl	Fluoxetine Hcl	61	18
Spironolactone	Spironolactone	60	17
Simvastatin	Simvastatin	59	21
Tizanidine Hcl	Tizanidine Hcl	59	35
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	57	47
Mirtazapine	Mirtazapine	56	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	52	16
Meclizine Hcl	Meclizine Hcl	52	29
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	50	13
Montelukast Sodium	Montelukast Sodium	48	19
Escitalopram Oxalate	Escitalopram Oxalate	46	20
Warfarin Sodium	Warfarin Sodium	44	11
Glimepiride	Glimepiride	42	17
Mounjaro	Tirzepatide	41	11
Clonazepam	Clonazepam	36	14
Atenolol	Atenolol	35	13
Memantine Hcl	Memantine Hcl	33	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	32	13
Citalopram Hbr	Citalopram Hydrobromide	31	11
Ezetimibe	Ezetimibe	31	14
Famotidine	Famotidine	31	14
Hydralazine Hcl	Hydralazine Hcl	31	13
Trulicity	Dulaglutide	31	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	30	suppressed
Finasteride	Finasteride	30	suppressed
Oxycodone Hcl	Oxycodone Hcl	30	11
Ozempic	Semaglutide	30	suppressed
Rybelsus	Semaglutide	30	suppressed
Clopidogrel	Clopidogrel Bisulfate	28	11
Diclofenac Sodium	Diclofenac Sodium	28	18
Quetiapine Fumarate	Quetiapine Fumarate	28	12
Zolpidem Tartrate	Zolpidem Tartrate	28	12
Synthroid	Levothyroxine Sodium	27	11
Valsartan	Valsartan	26	suppressed
Amoxicillin	Amoxicillin	25	15
Buspirone Hcl	Buspirone Hcl	25	12
Triamcinolone Acetonide	Triamcinolone Acetonide	24	16
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Ibuprofen	Ibuprofen	23	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	22
Ondansetron Odt	Ondansetron	23	18
Fenofibrate	Fenofibrate,micronized	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	21	12
Lorazepam	Lorazepam	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Diazepam	Diazepam	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	16
Ipratropium Bromide	Ipratropium Bromide	19	12
Xarelto	Rivaroxaban	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Fluconazole	Fluconazole	18	13
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Ramipril	Ramipril	18	suppressed
Spiriva Respimat	Tiotropium Bromide	18	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Ketoconazole	Ketoconazole	17	15
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Naproxen	Naproxen	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Azithromycin	Azithromycin	14	12
Farxiga	Dapagliflozin Propanediol	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Topiramate	Topiramate	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	11
Baclofen	Baclofen	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Erythromycin	Erythromycin Base	12	suppressed
Temazepam	Temazepam	12	suppressed
Torsemide	Torsemide	12	suppressed
Cefdinir	Cefdinir	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Glipizide	Glipizide	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error